代谢营养不良与炎症多标志物指数与心导管患者死亡风险的关联
本研究在前瞻性纵向观察队列中,对接受心导管检查的患者计算代谢脆弱指数(MVX),该指数由六种血清生物标志物组合而成。亚组分析显示该关联在男女、老年与年轻个体、心血管与非心血管死亡、有无多种共病患者中相似。
要点
- MVX由GlycA、小HDL、缬氨酸、亮氨酸、异亮氨酸和柠檬酸六种标志物组成,按性别特异性评分。
- 亚组分析提示MVX关联在老年与年轻、有无共病等亚组中相似。
核心结论
- MVX对心血管疾病患者及无基础疾病的低风险亚组的死亡预测均有主导贡献,提示代谢营养不良-炎症综合征在生存中的作用可能比既往认为的更普遍。
研究设计与样本
- 前瞻性纵向观察性队列研究,纳入CATHGEN生物样本库(2001年1月2日至2011年12月30日)和Intermountain Heart Collaborative Study(2000年9月12日至2006年9月21日)中接受冠状动脉造影且具有冷冻血浆核磁共振代谢组学数据的年龄≥18岁患者。
主要发现
- CATHGEN亚组分析显示MVX关联在男性与女性、老年与年轻个体、心血管与非心血管死亡、有或无多种共病患者中相似。
关键数值与推荐
- MVX由六种同时测量的血清生物标志物(GlycA、小HDL、缬氨酸、亮氨酸、异亮氨酸、柠檬酸浓度)组成,使用CATHGEN队列全因死亡预测模型的系数构建性别特异性多标志物评分。
- 采用Cox比例风险模型评估生物标志物及MVX与死亡率的关联,校正15项临床协变量。
临床怎么用
- MVX作为基于六种血清标志物的多标志物指数,可在接受心导管检查的患者中辅助识别5年死亡风险较高的个体,包括传统低风险亚组。
- 该指数有助于将代谢营养不良-炎症综合征纳入老年心血管病患者的风险评估框架,但尚需进一步验证。
局限性
- 研究为观察性设计,不能推断因果关系。
- MVX评分系数来源于CATHGEN队列,外部适用性需进一步验证。
- 研究人群为接受心导管检查的患者,结论推广至其他人群需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Complex and incompletely understood metabolic dysfunction associated with inflammation and protein-energy wasting contribute to the increased mortality risk of older patients and those with chronic organ diseases affected by cachexia, sarcopenia, malnutrition, and frailty. However, these wasting syndromes have uncertain relevance for patients with cardiovascular disease or people at lower risk. Studies are hampered by imperfect objective clinical assessment tools for these intertwined metabolic malnutrition and inflammation syndromes. We aimed to assess, in two independent cohorts of patients who underwent cardiac catheterisation, the mortality risk associated with the metabolic vulnerability index (MVX), a multimarker derived from six simultaneously measured serum biomarkers plausibly linked to these dysmetabolic syndromes. METHODS: In this prospective, longitudinal, observational study, we included patients aged ≥18 years recruited into the CATHGEN biorepository (Jan 2, 2001, to Dec 30, 2011) and the Intermountain Heart Collaborative Study (Sept 12, 2000, to Sept 21, 2006) who underwent coronary angiography and had clinical nuclear magnetic resonance metabolomic profiling done on frozen plasma obtained at catheterisation. We aggregated six mortality risk biomarkers (GlycA, small HDL, valine, leucine, isoleucine, and citrate concentrations) into sex-specific MVX multimarker scores using coefficients from predictive models for all-cause mortality in the CATHGEN cohort. We assessed associations of biomarkers and MVX with mortality in both cohorts using Cox proportional hazards models adjusted for 15 clinical covariates. FINDINGS: We included 5876 participants from the CATHGEN biorepository and 2888 from the Intermountain Heart study. Median follow-up was 6·2 years (IQR 4·4-8·9) in CATHGEN and 8·2 years (6·9-9·2) in the Intermountain Heart study. The six nuclear magnetic resonance biomarkers and MVX made strong, independent contributions to 5-year mortality risk prediction in both cohorts (hazard ratio 2·18 [95% CI 2·03-2·34] in the CATHGEN cohort and 1·67 [1·50-1·87] in the Intermountain Heart cohort). CATHGEN subgroup analyses showed similar MVX associations in men and women, older and younger individuals, for death from cardiovascular or non-cardiovascular causes, and in patients with or without multiple comorbidities. INTERPRETATION: MVX made a dominant contribution to mortality prediction in patients with cardiovascular disease and in low-risk subgroups without pre-existing disease, suggesting that metabolic malnutrition-inflammation syndromes might have a more universal role in survival than previously thought. FUNDING: Labcorp.
引用
- Otvos JD, Shalaurova I, May HT, et al. Multimarkers of metabolic malnutrition and inflammation and their association with mortality risk in cardiac catheterisation patients: a prospective, longitudinal, observational, cohort study. Lancet Healthy Longev. 2023. PMID: 36738747. doi:10.1016/S2666-7568(23)00001-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。